Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Behav Neurol. 2023 Jul 25;2023:2307443. doi: 10.1155/2023/2307443. eCollection 2023.
Dementia is a severe neurodegenerative disorder and it is a group of acquired symptoms associated with impaired cognitive functions. In low-income settings particularly in Sub-Saharan Africa (SSA), it is often seen as part of normal aging. Environmental, behavioral, and lifestyle interventions have the potential to alter the disease course of dementia.
This study is aimed to synthesize the literature/evidence(s) on the management practice and treatment outcomes of dementia in SSA.
Comprehensive literature was searched in PubMed database, Cochrane Library, and Google Scholar. Eligibility has been set, and based on the criteria, initially, a total of 442 results were obtained, and from those around 183 articles were duplicated. After examining titles and abstracts of records 26 articles were identified. Finally, five randomized clinical trials (RCT) and three prospective cohort studies that were reported on the management practice and treatment outcome of dementia in SSA were eligible for analysis. RCT and prospective cohort studies were used to strengthen the quality of evidence. The quality of the included RCT studies was assessed by using the Cochrane Risk of Bias Tool.
A total of 2781 patient data were included in the final analysis. Of these, 2354 patients were obtained from 5 RCTs and 427 patients from 3 prospective cohort studies, which were conducted in SSA countries. RCT studies were done on the feasibility and clinical effectiveness of cognitive stimulation therapy (CST) showed improvements in language memory domains and physical health. In addition, studies that focus on the management of human immunodeficiency virus-associated dementia (HIVAD) were reported to improve neurocognitively.
CST is applicable in low-resource settings and it shows improvements in cognitive function and quality of life. Early initiation of combination antiretroviral therapy in resource-limited settings has been associated with improvement in the cognitive function of HIVAD.
痴呆是一种严重的神经退行性疾病,是一组与认知功能障碍相关的获得性症状。在低收入环境中,特别是在撒哈拉以南非洲(SSA),它通常被视为正常衰老的一部分。环境、行为和生活方式干预有可能改变痴呆的疾病进程。
本研究旨在综合 SSA 地区痴呆管理实践和治疗结果的文献/证据。
在 PubMed 数据库、Cochrane 图书馆和 Google Scholar 中全面搜索文献。设定了合格标准,最初共获得 442 项结果,其中约 183 项是重复的。在检查了记录的标题和摘要后,确定了 26 篇文章。最后,有 5 项随机临床试验(RCT)和 3 项前瞻性队列研究符合纳入标准,这些研究报告了 SSA 地区痴呆的管理实践和治疗结果。RCT 和前瞻性队列研究用于增强证据质量。使用 Cochrane 偏倚风险工具评估纳入的 RCT 研究的质量。
共有 2781 名患者的数据纳入最终分析。其中,5 项 RCT 获得 2354 名患者,3 项前瞻性队列研究获得 427 名患者,这些研究均在 SSA 国家进行。RCT 研究评估了认知刺激疗法(CST)的可行性和临床效果,结果显示语言记忆域和身体健康方面有所改善。此外,关于人类免疫缺陷病毒相关性痴呆(HIVAD)管理的研究也报告了神经认知功能的改善。
CST 在资源匮乏的环境中是可行的,并且可以改善认知功能和生活质量。在资源有限的环境中早期开始联合抗逆转录病毒治疗与 HIVAD 认知功能的改善有关。